BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE. Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'? Eur J Neurol 2018;25:925-33. [PMID: 29528545 DOI: 10.1111/ene.13622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Fowler K, Mucha J, Neumann M, Lewandowski W, Kaczanowska M, Grys M, Schmidt E, Natenshon A, Talarico C, Buck PO, Diaz-Decaro J. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health 2022;22:1659. [PMID: 36050659 DOI: 10.1186/s12889-022-13971-7] [Reference Citation Analysis]
2 Grut V, Biström M, Salzer J, Stridh P, Jons D, Gustafsson R, Fogdell-Hahn A, Huang J, Brenner N, Butt J, Bender N, Lindam A, Alonso-Magdalena L, Gunnarsson M, Vrethem M, Bergström T, Andersen O, Kockum I, Waterboer T, Olsson T, Sundström P. Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study. Eur J Neurol 2021;28:3072-9. [PMID: 34107122 DOI: 10.1111/ene.14961] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
3 Gugliesi F, Pasquero S, Griffante G, Scutera S, Albano C, Pacheco SFC, Riva G, Dell'Oste V, Biolatti M. Human Cytomegalovirus and Autoimmune Diseases: Where Are We? Viruses 2021;13:260. [PMID: 33567734 DOI: 10.3390/v13020260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bach JF. Revisiting the Hygiene Hypothesis in the Context of Autoimmunity. Front Immunol 2020;11:615192. [PMID: 33584703 DOI: 10.3389/fimmu.2020.615192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dominguez-Mozo MI, Perez-Perez S, Villarrubia N, Costa-Frossard L, Fernandez-Velasco JI, Ortega-Madueño I, Garcia-Martinez MA, Garcia-Calvo E, Estevez H, Luque Garcia JL, Torrejon MJ, Arroyo R, Villar LM, Alvarez-Lafuente R. Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls. Cells 2021;10:119. [PMID: 33435197 DOI: 10.3390/cells10010119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hayashi F, Isobe N, Glanville J, Matsushita T, Maimaitijiang G, Fukumoto S, Watanabe M, Masaki K, Kira JI. A new clustering method identifies multiple sclerosis-specific T-cell receptors. Ann Clin Transl Neurol 2021;8:163-76. [PMID: 33400858 DOI: 10.1002/acn3.51264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Thakolwiboon S, Zhao-fleming H, Karukote A, Pachariyanon P, Williams HG, Avila M. Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 2020;45:102393. [DOI: 10.1016/j.msard.2020.102393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Tarlinton RE, Martynova E, Rizvanov AA, Khaiboullina S, Verma S. Role of Viruses in the Pathogenesis of Multiple Sclerosis. Viruses 2020;12:E643. [PMID: 32545816 DOI: 10.3390/v12060643] [Cited by in Crossref: 17] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
9 Zabalza A, Vera A, Alari-Pahissa E, Munteis E, Moreira A, Yélamos J, Llop M, López-Botet M, Martínez-Rodríguez JE. Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis. J Neuroinflammation 2020;17:161. [PMID: 32434524 DOI: 10.1186/s12974-020-01840-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
10 Maple PA, Tanasescu R, Gran B, Constantinescu CS. A different response to cytomegalovirus (CMV) and Epstein–Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls. Journal of Infection 2020;80:320-5. [DOI: 10.1016/j.jinf.2019.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
11 Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE. Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Front Immunol 2019;10:2403. [PMID: 31681293 DOI: 10.3389/fimmu.2019.02403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]